Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03297775
What this trial is testing

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

Who this might be right for
Rheumatoid ArthritisInterstitial Lung Disease
University of Colorado, Denver 750
Large-scale testing (Phase 3)Study completedNCT01570764
What this trial is testing

Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic SclerosisSclerodermaInterstitial Lung Disease+1 more
Assistance Publique - Hôpitaux de Paris 40
Not applicableUnknownNCT03854565
What this trial is testing

Glycocalyx Biomarkers in ARDS for Clinical Prognosis and Pulmonary Fibrosis

Who this might be right for
ARDS, HumanEndothelial DysfunctionMechanical Ventilation Pressure High
Southeast University, China 336
Not applicableStudy completedNCT00362739
What this trial is testing

Blood Collection From Individuals With Lung Disease for Genetic Studies

Who this might be right for
AsthmaCOPDInterstitial Lung Disease+2 more
Weill Medical College of Cornell University 3,087
Not applicableLooking for participantsNCT06756230
What this trial is testing

Downhill Walking in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Saglik Bilimleri Universitesi 34
Large-scale testing (Phase 3)Ended earlyNCT01777737
What this trial is testing

Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole

Who this might be right for
Idiopathic Pulmonary Fibrosis
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 3
Testing effectiveness (Phase 2)UnknownNCT01917877
What this trial is testing

Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

Who this might be right for
Pulmonary Fibrosis
Qingdao Central Hospital 30
Not applicableUnknownNCT04409275
What this trial is testing

LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION

Who this might be right for
Pulmonary Fibrosis
Fundación para la Investigación del Hospital Clínico de Valencia 500
Not applicableStudy completedNCT02818712
What this trial is testing

Health-related Quality of Life and Comorbidities in Danish Patients With Idiopathic Pulmonary Fibrosis - a Nationwide Follow-up

Who this might be right for
Idiopathic Pulmonary Fibrosis
Aarhus University Hospital 150
Testing effectiveness (Phase 2)Study completedNCT02036970
What this trial is testing

Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT

Who this might be right for
Pulmonary Arterial HypertensionPulmonary HypertensionInterstitial Lung Disease+9 more
Biogen 166
Large-scale testing (Phase 3)Study completedNCT03018041
What this trial is testing

The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation

Who this might be right for
Kidney Transplantation
Joe Chan 174
Testing effectiveness (Phase 2)Study completedNCT04396756
What this trial is testing

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT04533022
What this trial is testing

Safety, Efficacy and Pharmacokinetics of C21 in Subjects With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vicore Pharma AB 52
Not applicableUnknownNCT03560154
What this trial is testing

Effects of Whole Body Vibration Training in Patients With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseSclerodermaIdiopathic Pulmonary Fibrosis
Istanbul University 60
Large-scale testing (Phase 3)Looking for participantsNCT06125327
What this trial is testing

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 210
Testing effectiveness (Phase 2)Study completedNCT02846324
What this trial is testing

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

Who this might be right for
Idiopathic Pulmonary FibrosisHypoxemia
Global Blood Therapeutics 39
Post-approval studies (Phase 4)Study completedNCT02579603
What this trial is testing

Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 105
Early research (Phase 1)UnknownNCT06482190
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd 72
Post-approval studies (Phase 4)Study completedNCT04619680
What this trial is testing

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

Who this might be right for
Pulmonary FibrosisInterstitial Lung DiseaseRespiratory Disease
Icahn School of Medicine at Mount Sinai 103
Testing effectiveness (Phase 2)Study completedNCT00189176
What this trial is testing

Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 23
Next Page